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Acholeplasma laidlawii BGS10 [cyclo-(VKLdYPVKLdYP)] is a synthetic analog of the naturally occurring antimicrobial peptide gramicidin
(GS) in which the two positively charged ornithine (Orn) residues are replaced by two positively charged lysine
(Lys) residues and the two less polar aromatic phenylalanine (Phe) residues are replaced by the more polar
tyrosine (Tyr) residues. In this study, we examine the effects of these seemingly conservative modiﬁcations to
the parent GS molecule on the physical properties of the peptide, and on its interactions with lipid bilayer
model and biological membranes, by a variety of biophysical techniques. We show that although GS10 retains
the largely β-sheet conformation characteristic of GS, it is less structured in both water and membrane-
mimetic solvents. GS10 is also more water soluble and less hydrophobic than GS, as predicted, and also exhibits
a reduced tendency for self-association in aqueous solution. Surprisingly, GS10 associates more strongly with
zwitterionic and anionic phospholipid bilayer model membranes than does GS, despite its greater water
solubility, and the presence of anionic phospholipids and cholesterol (Chol) modestly reduces the association
of both GS10 and GS to these model membranes. The strong partitioning of both peptides into lipid bilayers is
driven by a large favorable entropy change opposed by a much smaller unfavorable enthalpy change. However,
GS10 is also less potent thanGS at inducing inverted cubic phases in phospholipid bilayermodelmembranes and
at inhibiting the growth of the cell wall-less bacterium Acholeplasma laidlawii B. These results are discussed in
terms of the comparative antibiotic and hemolytic activities of these peptides.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The structure, physical properties and mechanism of action of anti-
microbial peptides have been the focus of considerable fundamental
and applied research interest in recent years [1–3]. Antimicrobial
peptides are produced by a number of microorganisms and are widely
distributed in animals and plants, where they form part of the innateFP] (the amino acid immedi-
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ights reserved.immune defensemechanism of the host species. Antimicrobial peptides
are currently being investigated as potential sources of novel therapeu-
tic antibiotics to combat the increasing numbers of microorganisms
resistant to conventional antibiotics [1–5]. They exist in a wide variety
of structural motifs (α-helical, β-sheet, linear and cyclic), [6,7] but
almost all are cationic amphiphilic molecules which can interact with
the bacterial inner membrane, the lipid bilayer of which appears to be
their primary target. The mode of action of most antimicrobial peptides
is thought to involve initial electrostatic interaction between anionic
phospholipids on the outer monolayer of the bacterial membrane and
the cationic amino acid residues of the peptide, followed by partial
penetration of the peptide into the lipid bilayer, thus allowing the
hydrophobic amino acid residues of the peptide to contact the hydro-
carbon chains of the phospholipids. These peptides are believed to kill
bacteria by compromising the structural and functional integrity of the
phospholipid bilayer of the target membrane [1–7].
The antimicrobial peptide gramicidin S (GS) was ﬁrst isolated from
the Gram-positive bacterium Bacillus brevis [8] and is one of a series of
antimicrobial peptides produced by that organism [9,10]. GS is a cyclic
cationic decamer (primary structure cyclo[VOLdFPVOLdFP]) in which
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terminated on each side by a type II β-turn formed by the two D-Phe-
Pro sequences. It thus folds into a fairly rigid amphipathic structure in
which the two polar positively charged Orn side chains project from
one side and the four hydrophobic Leu and Val side chains project
from the other side (Fig. 1). This structure is stabilized by cross-ring
intramolecular hydrogen bonds, involving the amide protons and car-
bonyl groups of the two Leu and two Val residues [9,10]. GS is a power-
ful antibiotic against a broad range of Gram-negative andGram-positive
bacteria as well as against several pathogenic fungi [9,10]. However, GS
is also highly hemolytic and as a result, its therapeutic use is restricted to
topical applications [8]. Structure–activity studies of GS analogs have
shown that the expression of antibiotic activity is contingent upon the
retention of a β-sheet conformation in which cationic and hydrophobic
side chains are segregated on opposite faces of the molecule [9,10].
A great deal of evidence exists that the major target of GS is the lipid
bilayer of bacterial or erythrocytemembranes and that this peptide kills
bacteria cells and lyses erythrocytes by permeabilizing and destabilizing
their cytoplasmicmembranes [1,9–11].We have studied the interaction
of GSwith a variety of lipid bilayermodelmembranes using a number of
biophysical techniques in order to determine themolecularmechanism
of action [10,11]. In particular, DSC studies have shown that GS more
strongly perturbs the thermotropic phase behavior of anionic as com-
pared to zwitterionic phospholipid bilayers and of more ﬂuid as com-
pared to less ﬂuid membranes [12], and densitometry and sound
velocity studies indicate that GS incorporation decreases the density
and volume compressibility of the host phospholipid bilayer by increas-
ing the conformational disorder and motional freedom of the phospho-
lipid hydrocarbon chains [13]. 31P NMR [14] and X-ray diffraction [15]
studies also indicate that GS at low concentrations causes the thinning
of phospholipid bilayers and can induce the formation of inverted
nonlamellar cubic phases in phospholipid dispersions at higher concen-
trations. FTIR spectroscopic studies also show that GS is located in the
polar/apolar interfacial region of phospholipid bilayers and that it pen-
etrates more deeply into anionic and more ﬂuid bilayers [16]. As well,
several physical techniques indicate that the presence of Chol attenu-
ates all of the above effects of GS on phospholipid bilayers, at least in
part by reducing the penetration of this peptide into thesemodelmem-
branes [16,17]. Finally, a solid-state 19F NMR study of a 19F-labeled GS
analog suggests that the GS molecule is aligned with its cyclic β-sheet
lyingﬂat in the plane of the bilayer,with its polar and positively charged
Orn residues projecting toward the bilayer surface, where they can in-
teract with negatively charged phosphate headgroups of the phospho-
lipid molecules, while the four hydrophobic Val and Leu residues
project toward the bilayer center, where they interact with the phos-
pholipid hydrocarbon chains [18]. The location and orientation of GS
as deduced from the biophysical studies noted above are both consis-
tent with the results of recent electrophysiological experimentsFig. 1. The chemical structures and conformations of GS10 (left) and GS (right) shown
edge-on to the plane of the cyclic decapeptide ring. The two positively charged Lys
(GS10) or Orn (GS) amino acid residues are shown projecting upwards and the four hy-
drophobic Leu and Val residues are shown projecting downward. Carbon atoms are
shown in green, hydrogen atoms in white, oxygen atoms in red and nitrogen atoms in
blue.demonstrating that GS increases the conductivity of phospholipid
black lipid membranes without the formation of discrete pores or
channels [19].
We have also shown that strongly antimicrobial GS analogs with
markedly reduced hemolytic activity can be obtained by simultaneously
altering both the ring size and the enantiomeric conformation of key
amino acid residues [20–23], thus opening the way for the possible de-
velopment of further GS analogs for use as potent oral or injectable
broad-spectrum antibiotics [24]. The parent compound for these diaste-
reomeric ring-size analogs is GS10, inwhich the two relatively polar and
positively charged Orn residues of GS were replaced by the slightly less
polar but still positively charged Lys residues, and the two less polar
aromatic Phe residues were replaced by the more polar aromatic Tyr
residues (Fig. 1). These conservative changes in the GS molecule were
implemented in order to increase the aqueous solubility of GS10
analogs and to introduce an intrinsic ﬂuorescent label so that non-
perturbing spectroscopic experiments can be performed (Tyr for Phe
substitutions), and to make them less expensive to synthesize (Lys for
Orn substitutions), hopefully without signiﬁcantly altering the confor-
mation, physical properties and antibiotic activity. In fact, GS10 does
seem to retain the β-sheet conformation of GS and to exhibit at least
roughly comparable antibiotic andhemolytic activities [20–24]. Howev-
er, the conformations and relative amphipathicities of GS andGS10have
not been previously determined under strictly comparable conditions,
and the effect of GS10 on the lamellar/nonlamellar phase propensity
of phospholipid model membranes and its antibiotic activity against
the cell wall-less Mollicute Acholeplasma laidlawii B relative to GS itself,
have also not been studied. These comparisons are important for a full
understanding of the relationship of the structure and physical proper-
ties of these two antimicrobial peptides to their antimicrobial activities,
since GS10 rather than GS serves as the platform for the development of
promising diastereomeric ring-size analogs. In this regard, it is impor-
tant to separate changes resulting from alterations in the amino acid
composition of GS10 relative to GS itself from changes resulting from
ring expansion and enantiomeric inversions in the various GS10 ana-
logs. As well, we also present ITC results for the binding of GS and
GS10 to a variety of phospholipid model membranes and compare the
results obtained to previous ITC studies of GS itself [25] and of
GS14dK4, a diastereomeric ring-size analog exhibiting a highly retained
antimicrobial activity but a markedly reduced hemolytic potency [26].
2. Materials and methods
2.1. Lipid and peptides
Phospholipids and Cholwere purchased fromAvanti Polar Lipids Inc.
(Alabaster, AL, USA) and usedwithout further puriﬁcation. Linear deriv-
atives of the required cyclic peptides were synthesized by solid-phase
methods using t-butyloxycarbonyl chemistry and then N- to C- (Pro at
the C-terminus) terminally cyclized in solution, as described previously
[27]. The products were then puriﬁed and analyzed by RP-HPLC and
their ﬁnal purity determined by mass spectrometry. Stock solutions of
the pure peptides were prepared in methanolic solution and their
concentrations determined by amino acid analysis (±5% error). Aque-
ous solutions of these peptides were then prepared by drying down
known volumes of the stock solution and subsequently redissolving
the peptide ﬁlm in an appropriate volume of aqueous buffer to obtain
the peptide concentration required. Unless otherwise stated, all experi-
ments were performed in a buffer composed of 50 mM Tris, 150 mM
NaCl and 1 mM NaN3, pH 7.4.
2.2. Circular dichroism
CD spectra were recorded with a Jasco J-720 spectropolarimeter
(Easton, MD) using quartz cells of 2 mm path length. The spectra
were measured using ~50 μM peptide solutions in aqueous- (10 mM
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50 vol.% TFE) buffer at 20 °C.
2.3. RP-HPLC
Reversed-phase high performance liquid chromatographic analyses
were performed on a Zorbax 300SB-C8 column (150 × 2.1-mm inner
diameter, 3.5 μm particle size, 300 Å pore size; Rockland Technologies,
Wilmington, DE) using an Agilent 1100 liquid chromatograph (Agilent
Technologies, Little Falls, DE) with a linear AB gradient of 0.5% B/min
(solvent A: 0.2% aqueous triﬂuoroacetic acid; solvent B: 0.18%
triﬂuoroacetic acid in acetonitrile) at a ﬂow rate of 0.3 ml/min. Reten-
tion times were recorded at temperatures between 5 °C and 80 °C
(3 °C increments) using the temperature proﬁling RP-HPLC protocols
described previously [28].
2.4. 31P NMR spectroscopy
31P-NMR spectra were recorded as a function of temperature with a
Varian Unity-300 spectrometer operating at 121.41 MHz for 31P, using
data acquisition and data processing protocols similar to those
described previously [14]. Peptide-free and peptide-containing DPEPE
vesicles (with and without Chol) were also prepared for 31P NMR spec-
troscopy using the same methods previously used in this laboratory
[14].
2.5. Antimicrobial activity
The cellwall-lessMollicute A. laidlawii Bwas cultured in chloroform-
extracted BSA-free media and cell growth was monitored
turbidometrically [29]. The effect of the antimicrobial peptides on cell
growth was monitored as a function of time after the addition of these
peptides to the culture medium just prior to a 10% (by volume) inocu-
lation with cells in the mid log phase of growth. Cell growth was
expressed as a percentage of the maximum growth obtained in the ab-
sence of a peptide. Growth yields were plotted as a function of peptide
concentration and growth inhibitory activity was expressed in terms of
an apparent LD50 using methods similar to those previously utilized in
this laboratory [30].
2.6. High-sensitivity isothermal titration calorimetry
The heat ﬂow resulting from the association of the peptide to lipid
vesicles was measured using a high-sensitivity VP-ITC instrument
(Microcal LLC, Northampton, MA) with a reaction cell volume of
1.448 ml [31]. Prior to use, solutions were degassed under vacuum
(140 mbar, 8 min) to eliminate air bubbles. The data were acquired by
computer software developed by MicroCal LLC. Titration calorimetric
experiments were performed as follows. The peptide solution (25–60)
was placed in the calorimeter cell and the lipid vesicles (2.5–38 mM)
were injected via the titration syringe in aliquots of 4–10 ml. Each injec-
tion produced a heat of reaction, which was determined by integration
of the heat ﬂow tracings. This mode is capable of providing both the
binding isotherm and the total binding enthalpy [31–33].
The heat of dilution was determined in control experiments by
injecting the corresponding vesicle dispersion into the buffer solution.
The heats of dilution were subtracted from the heats determined in
the corresponding peptide–lipid titration experiments. The overall as-
sociation enthalpy and association isotherm were determined from
these peptide–lipid titration experiments using standard procedures
[31–33] and the data were analyzed and ﬁtted as described [34]. Since
our dynamic light scattering experiments and the results of other stud-
ies indicated that these antimicrobial peptides do not cause the fusion
or disruption of the LUVs utilized in the ITC titrations under the experi-
mental conditions employed here,we usedhalf of the total lipid concen-
tration in the estimation of the degree of association and thedetermination of the thermodynamic association parameters, since
these antimicrobial peptides appear to initially have access only to the
outer monolayer of the phospholipid bilayer.
The single- and multi-component large unilamellar lipid vesicles
used in these ITC studies were prepared as follows. In a typical experi-
ment, speciﬁed amounts of lipid (~60 mg) were ﬁrst dried under
reduced pressure (vacuum) overnight. The lipid was then hydrated
with an appropriate amount of buffer (~2 ml) and the dispersion thus
formed was subjected to vortex mixing at temperatures well above
the gel/liquid-crystalline phase transition temperature of the phospho-
lipids. The multilamellar vesicles thus obtained were then freeze–
thawed several times. These vesicles were then extruded through a
small volume extrusion apparatus (Avestin Inc., Ottawa, Canada)
equipped with polycarbonate membrane ﬁlter (19 mm diameter,
200 nm pore diameter) about 25 times, in order to produce LUVs of
vesicle size ~200 nm. Lipid concentrations were determined by gas
chromatography using an appropriate internal standard (±5% error).
The same procedure was followed for two-component vesicles, except
that appropriate quantities of each component (lipid or Chol) were
ﬁrst co-dissolved in chloroform and thoroughly mixed prior to vesicle
preparation.
2.7. Dynamic light scattering
The average hydrodynamic diameter of pure and peptide-bound
LUVs were measured by a Brookhaven BI-90 particle Analyzer
(Brookhaven Instruments, Holtsville, NY) equipped with disposable
square cells. The solutions were subjected to scattering by a monochro-
matic light (10 mW He–Ne laser, wavelength = 632.4 nm) and the
scattered light intensity was measured at a scattering angle of 90°.
3. Results
3.1. Reversed-phase HPLC studies
The binding afﬁnity of a peptide to a RP-HPLC column is determined
by its effective hydrophobicity, with more hydrophobic peptides
exhibiting stronger binding to the hydrophobic stationary phase and
thus greater retention times [28]. Illustrated in Fig. 2A are plots of the
absolute RP-HPLC retention times of GS10 as a function temperature.
For comparative purposes, similar plots for GS are also presented. The
RP-HPLC retention times of GS10 are signiﬁcantly shorter than those
of GS, indicating that GS10 has a lower propensity for binding to hydro-
phobic surfaces under all conditions examined. Given the structural and
conformational similarities between GS and GS10, these differences in
retention times undoubtedly reﬂect differences between the intrinsic
hydrophobicities of these two molecules due to their different amino
acid compositions. Speciﬁcally, the replacement of the two Phe residues
of GS by themore polar Tyr residues would be expected to decrease the
hydrophobicity of GS10 relative to GS itself, despite the fact that the two
Orn residues of GS are replaced by slightly more hydrophobic Lys resi-
dues in GS10.
Fig. 2A also shows that the retention times of both GS and GS10 on
RP-HPLC columns exhibit a biphasic response to temperature change.
At low temperatures (b45–50 °C), the retention times of GS and GS10
increase with temperature up to a maximal value near 45–50 °C,
beyond which further increases in temperature are accompanied by
monotonic decreases in RP-HPLC retention times. In cases where in-
creases in temperature are not accompanied by the exposure of occlud-
ed hydrophobic surfaces, peptide RP-HPLC retention times actually
decrease monotonically with temperature (for an example, see the
plot for the linear reference peptide shown Fig. 2A and B), because of
the effects arising from thermally induced decreases in solvent viscosity,
increases in solute diffusivity and mass transfer, etc. [28]. However,
whenever increases in temperature also increase the probability of ex-
posing occluded hydrophobic surfaces, the thermally induced decrease
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Fig. 2.Temperature-proﬁlingHPLC studies of thepeptidesGS andGS10. Comparable data are also presented for the linear non-associatingpeptide, AKAKAdYPAKAKAdYPwhich serves as a
reference for these studies. Plots of absolute RP-HPLC retention times are presented in panel A and plots of RP-HPLC retention times relative to values measured at 5 °C are presented in
Panel B. Data are presented for the peptides, Gramicidin S ( ), GS10 (( ) and the non-associating reference ( ).
Fig. 3. CD spectra exhibited by GS and GS10 in aqueous and TFE-containing buffer. The
spectra shown were acquired at peptide concentrations near 50 mM and are representa-
tive of: GS10 in aqueous buffer; GS10 in TFE-containing buffer; GS in aqueous buff-
er; GS in TFE-containing buffer.
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even increasewith temperature, depending on the nature of the process
involved and the relative sizes of the thermally exposed hydrophobic
surfaces [28]. For conformationally stable peptides such as GS and
GS10, a change in the degree of self-association is the only process
whereby a thermally induced exposure of occluded hydrophobic sur-
faces can occur. Consequently, we can interpret a positive deviation of
the temperature dependence of the RP-HPLC retention times of these
peptides relative to that of a non-associating reference in terms of
changes in the propensity of the peptide to self-associate in aqueous
media. This novel “RP-HPLC temperature proﬁling” approach to assessing
peptide self-association has been successfully applied to amphipathic
cyclic β-sheet peptides based on gramicidin S [24,28], amphipathic
α-helical peptides, including monitoring of unfolding of the α-helix
to random coil with increasing temperature [35], and amphipathic
α-helical peptides that form two-stranded α-helical coiled-coils [36].
Signiﬁcantly, the proﬁling results with the latter peptides also correlat-
ed with coiled-coil stability determined bywell-established biophysical
approaches. This now established method has also helped further the
development of antimicrobial peptides due to its correlation with anti-
microbial and hemolytic activities [37–40]. We can thus conclude from
the results presented in Fig. 2A and B that GS and GS10 both exhibit ap-
preciable propensities for self-association in aqueous buffer. Moreover,
when the RP-HPLC retention times of GS and GS10 are plotted relative
to those observed at 5 °C, it becomes apparent that at all temperatures
below 60 °C, GS consistently exhibits larger deviations from the behav-
ior of the non-associating reference than GS10 (Fig. 2B). This observa-
tion indicates that GS has a consistently higher propensity for self-
association in aqueous buffer than GS10, although as gaged by the
parameters plotted in Fig. 2B, the differences in the magnitudes of the
self-association parameters of GS to GS10 are not drastic. These small
differences between the self-association parameters of GS and GS10
probably reﬂect the relatively small changes in hydrophobicity incurred
in replacing the Phe residues of GS with Tyr, and the fact that the loca-
tion of the Phe residues at the edges of the hydrophobic face of GS is
such that their replacement with Tyr would not markedly reduce
the size of the contiguous hydrophobic surface of the peptide [41].
However, one should note that although the magnitude of differencesbetween the self-association parameters of GS and GS10 is small, the
units of these parameters are actually HPLC retention times, which
have an exponential relationship to the underlying thermodynamic
equilibria and are thus reﬂecting disproportionally larger differences
in association/dissociation equilibria of these peptides.3.2. Circular dichroism studies
Illustrated in Fig. 3 is a comparison of the CD spectra exhibited by GS
and GS10 in both aqueous and so-called membrane-mimetic media.
10 mM acetate buffer (pH 5.5) was used for these studies because,
unlike GS10, GSwas not sufﬁciently soluble in 10 mMphosphate buffer
(pH 7.0) to enable the acquisition of the CD spectra of GS and GS10
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molar ellipticity proﬁles exhibited by aqueous solutions of the two pep-
tides are very similar, suggesting that they sharemany common confor-
mational features. However, as noted previously [20,21], the molar
ellipticity proﬁles of these peptides are atypical of proteins with a high
β-sheet structure content, probably because of signiﬁcant contributions
from the relatively high content of β-turn structure (~40 residue %)
and the aromatic residues (~20 residue %). However, the magnitudes
of the molar ellipticities of GS and GS10 near 222 nm are quite large
(~−30,000), these values increase signiﬁcantly when the peptides are
transferred from aqueous to so-called membrane-mimetic media, and
the molar ellipticity values of GS near 222 nm are always greater in
magnitude than that of GS10 under comparable conditions. Also, GS
exhibits a signiﬁcantly greater change in its molar ellipticity proﬁle
upon transfer from aqueous to membrane-mimetic media than does
GS10. We therefore conclude that these two peptides both retain a
high degree of antiparallel β-sheet structurewhen dissolved in aqueous
media, and that their secondary structure content increaseswhen trans-
ferred to membrane-mimetic solvents (i.e., their secondary structures
exhibit signiﬁcant solvent inductibility). Nevertheless, GS10 is less
structured than GS in both aqueous and membrane-mimetic media
and less sensitive to changes in the polarity of the solvent than is GS.
The probable physical basis and implications of these observations will
be explored later in the Discussion.
3.3. A. laidlawii B growth inhibition studies
We study the effects of GS10 on the growth of the mycoplasma
A. laidlawii B here because the absence of a cell wall in this bacterium
makes the interpretation of the results obtained, and their comparison
with the effects of GS10 on the various lipid bilayer model membranes
studied here and previously, more straightforward. This is because
some GS analogs exhibit weak antibiotic activity due to their strong
binding to the cell walls of conventional bacteria, although they also
bind strongly to and potently disrupt lipid bilayer model membranes
[20,21,30]. The weak growth inhibiting abilities of these GS analogs
are thus presumably due to the fact that high concentrations of these
peptides must be added to saturate cell wall binding before an interac-
tion with the lipid bilayer of the bacterial inner membrane can take
place. Therefore, by studying the effects of GS10 on the growth of this
organism, we can more accurately determine the “intrinsic” antimicro-
bial activity of GS and its various analogs.
The effects of GS10 on A. laidlawii B growth are brieﬂy summarized
below, along with comparable data obtained with GS itself and the
weakly hemolytic GS ring-size analog GS14dK4. The antibiotic activity
of GS10 against A. laidlawii B (LD50 ~0.65 mM) is signiﬁcantly lower
than that of GS (LD50 ~0.17 mM), but somewhat higher than that of
the weakly hemolytic GS14dK4 (LD50 ~1.2 mM), observations consis-
tent with the results of previously published assays of the antimicrobial
activities of these peptides against various Gram-negativeand Gram-
positive bacteria [20,21,30]. The relationship between the biological ac-
tivity of GS10 and its capacity to interact with and perturb lipid mem-
branes was examined in the spectroscopic and calorimetric
measurements described below.
3.4. 31P NMR spectroscopic studies
Wehave presented evidence in previous studies that GS and its ring-
size analogs may destabilize lipid bilayer model and biological mem-
branes in part by increasing negative monolayer curvature stress, thus
promoting the formation of inverted cubic phases [14,15]. We have
thus also studied the ability of GS10 to induce such phases in DPEPE
aqueous dispersions. DPEPE is a particularly suitable phospholipid
for investigating these effects, since it exhibits lamellar gel/liquid-
crystalline and lamellar liquid-crystalline/inverted hexagonal phase
transitions at 22 and 92 °C, respectively, thus providing a broadtemperature interval over which the peptide-induced formation of
inverted lipid phases may be detected. Illustrated in Fig. 4A are represen-
tative 31P NMR spectra exhibited by GS10- andGS-containingDPEPE ves-
icles as a function of temperature. At all temperatures from 25 to 85 °C,
aqueous dispersions of DPEPE alone exhibit 31P NMR spectra typical of
unoriented liquid-crystalline phospholipid bilayers, in which lipid
phosphate headgroups are undergoing fast axially symmetric motion,
as expected in this temperature interval. At low temperatures, the spec-
tra exhibited by peptide-free and peptide-containing (4 mol%) DPEPE
membranes also exhibit spectra consistent with the presence of
DPEPE bilayers. However, at high temperatures, all of the GS- and
GS10-containing mixtures examined exhibit 31P NMR spectra which
contain a sharp peak centered near 2 ppm downﬁeld (the isotropic
component), which arises from the formation of an inverted cubic
phase [14,15]. However, the temperature range overwhich this process
occurs, and the extent to which it takes place, differ signiﬁcantly be-
tween the two peptides. As illustrated in Fig. 4B, the growth of the iso-
tropic component in Chol-free GS-containing DPEPE vesicles (T50
~52 °C) occurs over a lower temperature range and goes further toward
completion than that of the corresponding GS10-containing sample
(T50 ~67 °C), indicating that GS has a greater propensity for inducing
cubic phase formation. Fig. 3B also shows that in the presence of mem-
brane Chol (30 mol%), GS- and GS10-induced cubic phase formation is
shifted to higher temperatures (T50 ~61 °C for GS vs T50 ~80 °C for
GS10), indicating that membrane Chol inhibits the capacity of these
peptides to induce cubic phase formation in thesemembranes. Howev-
er, the inhibitory effect of Chol is quantitatively greater in the GS10-
containing system, indicating that Chol reduces the interactions of
GS10 with DPEPE bilayers to a greater extent than that of GS itself.
The probable thermodynamic basis of these and other differences be-
tween the properties of GS and GS10 are examined in the ITC studies
presented below.
3.5. ITC studies
ITC is a quick, reliable and versatile thermodynamic technique for
studying the association of antimicrobial peptides, detergents and other
amphiphiles with lipid bilayer model membranes [42,43]. We have ap-
plied this technique here to investigate the interactions of GS and GS10
with a number of LUVs having different lipid compositions. In particular,
we have studied the association of these two antimicrobial peptides with
lipid vesicles composed of the zwitterionic phospholipid POPC, the anion-
ic lipid POPG, and POPC/POPG mixtures (mole ratio 3:1), as well as mix-
tures of POPC/Chol and POPG/Chol (mole ratio 3:2). The ITC isotherms
obtained in each casewere then analyzed using a simple surface partition
model. In this model, the Gouy–Chapman theory is utilized to calculate
the peptide surface concentrations based on electrostatic interactions be-
tween the positively charged peptide molecules and initially neutral or
anionic phospholipid polar headgroups, and then a surface/bilayer mole
ratio partition coefﬁcient (K0) is determined [34]. K0 thus represents the
intrinsic or chemical component of the association process and is a mea-
sure of membrane afﬁnity after correction for electrostatic effects. We
present below the results of such an analysis for the association of GS
and GS10 with POPC, POPC/POPG and POPC/Chol LUVs, where high-
quality ITC data and good ﬁts with the above model were possible. In
the cases of POPG and POPG/Chol vesicles, both raw ITC data and model
ﬁts were much poorer, so we only make qualitative references to these
results. The poorer quality of the data and the corresponding ﬁts for
these latter two vesicle systems likely result from effects such as an in-
complete ionization of the phosphate moieties of the polar headgroups,
to increased counterion binding, etc., due to their high negative surface
charge density.
Representative ITC titrations of POPC LUVs into solutions of GS and
GS10 are presented in Fig. 5A and C, respectively, and the plots of the
normalized and integrated heats of association of these peptides with
POPC (solid symbols) and POPC/Chol (open symbols) LUVs, and their
Fig. 4. 31P NMR spectroscopic studies of the effect of GS and GS10 on the lamellar/nonlamellar phase behavior of DPEPE. Panel A is a representative data set illustrating temperature de-
pendent changes in the 31P NMR powder patterns exhibited by a DPEPE:GS mixture (25:1 mol:mol). Panel B shows the temperature dependent changes in the fractional area of the iso-
tropic component observed in spectra exhibited by the following mixtures: GS:DPEPE; GS:(DPEPE + Chol); GS10:DPEPE; GS10:(DPEPE + Chol). All lipid:peptide ratios were
25:1 and the Chol-containing mixtures contained 30 mol% Chol.
1425T. Abraham et al. / Biochimica et Biophysica Acta 1838 (2014) 1420–1429ﬁts to themodel, are presented in Fig. 5B and D. The ITC titrations reveal
that the initial endothermic heat of association decreases and levels off
to a constant heat of dilution value as the peptide in solution becomesFig. 5. Exemplary ITC data at 25 °C. LUVs at a total lipid concentration of 10 mMwere titrated in
initially endothermic heat of reaction decreased and leveled off at a constant heat of dilution a
panels (A,C): Baseline-corrected thermograms depicting differential heating power,Δp, versus t
integrated reaction heats,Q, versus lipid concentration in the sample cell, cL, as derived from titr
symbols). Also shown are the best ﬁts to the experimental data in terms of a surface partition eprogressively associated with the lipid vesicles added to the sample
cell, and the good ﬁt of the model to the experimental heats of
peptide/vesicle association are illustrated by the closeness of the solidto the sample cell (1.4448 ml) containing either 25 μMGS (A,B) or 60 μMGS10 (C,D). The
s virtually all of the peptides in the sample cell became adsorbed to the lipid vesicles. Top
ime, t, obtained upon titrationwith pure POPC LUVs. Bottompanels (B,D): Normalized and
ationswith LUVs composed of pure POPC (solid symbols) or a 6:4 POPC:Cholmixture (open
quilibrium modulated by electrostatic effects ([34]; see Table 1 for ﬁtting parameters).
Table 2
Hydrodynamic diameter of pure and the peptide-bound LUVs.
Model membrane Hydrodynamic diameter (d), nm
In buffer In GS10 solution
POPC 166 173
POPG 178 185
POPC:POPG (3:1) 179 185
POPC:Chol (6:4) 210 217
POPG:Chol (6:4) 179 190
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eters calculated for the association of GS and GS10 with POPC, POPC/
POPG and POPC/Chol LUVs are presented in Table 1.
The ﬁrst general result evident from Table 1 is that the K0 values for
both peptides in all three LUVs are very high, clustering around
1–2 × 107/M, indicating that both peptides partition very strongly
into all three phospholipid bilayer systems. Examination of the associat-
ed thermodynamic parameters reveals that the high negative ΔG°
values for peptide partitioning are due primarily to a very favorable
entropy change which is opposed by a much smaller unfavorable
change in enthalpy. This indicates that these antimicrobial peptides
are driven into phospholipid bilayer membranes primarily by hydro-
phobic interactions [44]. Also, the K0 value for the partitioning of GS
into these LUVs is about half that of GS10, due to a less favorable change
in enthalpy, albeit partially compensated for by amore favorable entro-
py change. Thus GS10 is more strongly associated with these lipid
model membranes, despite its higher solubility in water. Finally, the
presence of the negatively charged POPG in mixed POPC/POPG LUVs
appears to decrease K0 values modestly, particularly for GS10, as does
the presence of Chol in POPC/Chol vesicles, due primarily to slightly
more unfavorable enthalpy change. These same trends were observed
in the POPG and POPG/Chol vesicles, although the K0 values obtained
were less reliable (data not presented).
3.6. Size of pure and peptide-bound LUVs
It has been suggested previously that GS may induce phospholipid
vesicle fusion or even solubilize phospholipid, at least at higher concen-
trations of peptide [9–11]. In order to check the integrity of the LUVs
exposed to GS10 and to evaluate whether such effects contribute signif-
icantly to the ITC data presented above, dynamic light scattering
measurements were performed on both control vesicles (LUVs titrated
into buffer solution without peptide) and on the sample vesicles
(LUVs titrated into the peptide-containing buffer). The data are presented
in Table 2. Although the hydrodynamic diameters (d) of the peptide-
exposed lipid vesicles are always slightly greater than those of pure
lipid vesicles, these results indicate that the various LUVs studied here
remain largely intact and donot undergo extensive fusion in the presence
of GS10 under the experimental conditions employed in our ITC
measurements.
4. Discussion
It is clear that the changes in amino acid composition which trans-
formed GS into GS10 have increased the aqueous solubility of the mol-
ecule (see HPLC data) without drastically altering the conformational
properties of the peptide, as intended. However, these changes in
amino acid composition have affected somewhat other physicochemi-
cal properties of GS10, as well as its capacity to interact with bothTable 1
Thermodynamic parameters for the partitioning of GS and GS10 into LUVs of various lipid com
Lipid composition GS
K0
a
1/μM
ΔG°
kcal/mol
ΔH°
kcal/mol
−
kc
POPC 12
(11–14)
−12.0 3.4 −
POPC:POPG (3:1) 8.2
(7.2–9.5)
–11.8 3.7 −
POPC:Chol (6:4) 9.1
(7.8–11)
−11.9 3.2 −
a Hydrophobic mole ratio partition coefﬁcient, K0, standard molar Gibbs free energy, ΔG°, mo
iments performed at 25 °C. Isotherms such as those in Fig. 5 were generated from ITC raw data
partition equilibriummodulated by electrostatic effects [34] by using nonlinear least-squaresﬁtt
was assumed to be accessible to the peptide. Numbers in parentheses indicate 95% conﬁdencemodel and biological membranes. In particular, these modiﬁcations
have reduced both the content and the solvent inducibility of the sec-
ondary structure of GS10 relative to GS. This ﬁnding seems inconsistent
with the considerable body of experimental evidence indicating that the
conformation of theGS ring system is remarkably stable and quite resis-
tant to both thermal and solvent-induced change [9,10,45,46]. Howev-
er, a plausible explanation for these observations was suggested by 1H
NMR and molecular modeling studies of the GS ring-size analogs GS14
and GSdK14 [20,21]. A comparison of the NMR solution structures of
GSdK14 obtained in water and TFE/water indicates that the orientation
of the antiparallel-aligned VKLKV and LKVKL β-sheet sequences chang-
es with the polarity of the solvent, such that the formation of cross-ring
hydrogen bonds becomes more favorable as the TFE content of the
solvent increases. Thus, themain difference between the conformations
obtained in water and in TFE-containing media arises predominantly
from changes in the relative orientations of the β-sheet segments of
the peptide and not from changes in secondary structure per se. More-
over, our molecular modeling studies indicate that the deviation from
the geometry favoring cross-ring H-bonding which occurs when the
polarity of solvent increases also promotes closer contacts between
the hydrophobic side chains of the molecule, suggesting that this
process is driven by thermodynamic tendencies towards minimizing
contacts between the hydrophobic surfaces and water. We therefore
suggest that the occurrence of comparable phenomena in the GS and
GS10 ring systems can also account for the apparent conformational
sensitivity of these peptides to changes in solvent polarity, and for the
fact that GS is more sensitive than GS10 in this regard, since the greater
hydrophobicity of GS will provide a stronger driving force towards
reorienting its antiparallel β-sheets when the polarity of the solvent
changes.
Our 31P NMR spectroscopic studies clearly indicate that GS10 ex-
hibits a lower propensity for inducing inverted cubic phases in DPEPE
membranes than does GS, suggesting that GS10 has a lower propensity
thanGS for increasing negativemonolayer curvature stress in cellmem-
branes (the most probable mechanism underlying membrane disrup-
tion by these peptides) [14,15]. This observation is consistent with the
results of our A. laidlawii B growth inhibitory studies andwith previous-
ly published studies of the antimicrobial activities of GS and GS10positions.
GS10
ΤΔS°
al/mol
K0
a
1/M
ΔG°
kcal/mol
ΔH°
kcal/mol
−ΤΔS°
kcal/mol
15.4 28
(21–37)
−12.5 0.8 −13.4
15.5 9.3
(7.6–11)
−11.9 1.6 −13.5
15.1 18
(17–19)
−12.3 1.4 −13.7
lar transfer enthalpy, ΔH°, and entropic contribution,−TΔS°, as obtained from ITC exper-
with the aid of the public-domain software NITPIC [42] and analyzed in terms of a surface
ing [43]. The peptide chargenumberwas ﬁxed at+2, and only the outermembrane leaﬂet
intervals obtained by error-surface projection [51].
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the overall similarities in the structure, conformation and size of the
GS and GS10 molecules, it might seem unlikely that GS10 is inherently
markedly less disruptive of lipid bilayer integrity than GS itself. Thus,
it may be that the apparently lower propensity for GS10 to induce
cubic phases in DPEPE bilayers is primarily reﬂecting its higher aqueous
solubility and concomitant lower propensity for partitioning into DPEPE
membranes compared to GS, although GS10 binds more strongly to
zwitterionic POPC LUVs than does GS. Nevertheless, because of its
intrinsically lower hydrophobicity and lower amphipathicity, and the
fact that Tyr side chains have a greater afﬁnity for membrane polar/
apolar interfaces than Phe side chains [47–50], GS10 could be inherently
less disruptive thanGS because itmay not be able to penetrate as deeply
into lipid bilayer membranes as GS. Consequently, we cannot exclude
the possibility that there are differences between the inherent mem-
brane-disruptive capacities of GS andGS10which could be large enough
to make a signiﬁcant contribution to our experimental observations.
This aspect of the behavior of these antimicrobial peptides (and many
others) is currently unclear and the issue will probably remain unre-
solved until more precise information on the partitioning and depth of
penetration of these peptides into lipid bilayer membranes can be
obtained.
Another interesting aspect of our 31P NMR spectroscopic data is the
demonstration that membrane Chol attenuates the capacity of both GS
and GS10 to induce cubic phase formation in DPEPE membranes. This
phenomenon has been observed previously [17], and represents one
of the mechanisms whereby effective discrimination between bacterial
and animal cell membranes can occur [25,26]. Interestingly, however,
the 31P NMR spectroscopic data also indicate that membrane Chol-
induced attenuation of the membrane-disruptive tendencies of GS10
appears to be more pronounced than observed with GS itself. Thus,
the capacity of membrane Chol to attenuate the membrane-disruptive
activities of peptides such as these is also dependent upon the physico-
chemical properties of the peptide. This conclusion is also supported by
the results of our earlier and our present ITC studies, which suggest that
this effect may be attributable to a small differential reduction of the
binding of these peptides to Chol-rich phospholipid membranes. It
should therefore be feasible to exploit this property to design more
therapeutically useful GS analogs (see below).
The decreased ability of GS10 to inhibit the growth of the cell wall-
less prokaryote A. laidlawii B relative to GS itself is also consistent with
previous measurements of the antimicrobial activities of these two
peptides [20,21,30]. The results of these growth inhibitory studies are
positively correlated with the results of all of the physicochemical stud-
ies presented here except for the ITC results, and, because of the absence
of a cell wall in A. laidlawii B, these data may even be more accurately
reﬂecting the intrinsic propensities of these peptides to disrupt the
lipid bilayers of natural bacterial membranes. As noted above, our RP-
HPLC data provide indicate that GS10 is less hydrophobic than GS, that
it has a weaker tendency to aggregate in aqueous solution, and that it
has lower propensity for interaction with hydrophobic surfaces than
does GS. Consequently, GS10 should partition less strongly into the
polar/apolar interfacial regions of the lipid bilayers of the cytoplasmic
membranes of A. laidlawii B and conventional cell wall-containing bac-
teria than would GS itself. However, this conclusion is not supported
by the results of our ITC studies of the interactions of these peptides
with lipid bilayers, since GS10 binds more strongly than GS to all of
the phospholipid model membrane systems studied here. Therefore, it
appears that differences in the detailed chemical structures of these
two antimicrobial peptides, rather than differences in their overall
physical properties, may determine their antimicrobial potency and
toxicity.
A discussion of our ITC results for the binding of GS10 to various
phospholipid vesicles systems (unpublished data) and those obtained
previously for GS itself for these same phospholipid bilayers [25], but
analyzed without correcting for electrostatic effects, indicates thatGS10 binds more strongly and to a greater extent to zwitterionic POPC
LUVs than does GS, but that GS10 binds less strongly and to a smaller ex-
tent to anionic POPG LUVs than does GS.Moreover, the presence of Chol
in either POPC or POPG vesicles produces amuch greater decrease in the
degree and extent of GS10 binding than is the case for GS. Thus, the
binding of GS10 is much less sensitive to the charge of the phospholipid
vesicle, but much more sensitive to the order of the phospholipid vesi-
cles as determined by Chol content, than is GS itself. The stronger bind-
ing of GS10 to zwitterionic POPC LUVs relative to GS can be attributed
primarily to a smaller positive ΔH value for peptide binding, and the
weaker binding of GS10 to anionic POPG LUVs relative to GS is due pri-
marily to smaller positiveΔS and TΔS values. Similarly, themarkedly re-
duced binding of GS10 to Chol-containing POPC LUVs relative to GS is
also due primarily to a larger positive ΔH value, while the decreased
binding of GS10 to anionic POPG LUVs relative to GS is due primarily
to reduced positive ΔS and TΔS values. Overall, the ΔH values for GS10
binding to various phospholipid vesicle systems vary over a greater
range than for GS binding to these same systems, while the variations
in the range of the ΔS and TΔS values with phospholipid and Chol com-
position are comparable for both peptides. Since the results of studies of
antimicrobial potency and hemolytic activity cannot really be corrected
for electrostatic effects, the results of our previous ITC studies may be
more relevant to the biological activities of these peptides, albeit at
the cost of mechanistic and thermodynamic rigor.
It is also interesting to compare the results of our recent ITC studies
of the binding of GS14dK4 [26], a diastereomeric lysine ring-size analog
of GS, and of GS itself [25], to these obtained in the present ITC study of
GS10 binding to phospholipid vesicles of comparable compositions. In
general, the strength of binding of GS14dK4 is much more signiﬁcantly
inﬂuenced by the phospholipid and Chol composition of the LUVs, in
particular by phospholipid surface charge density and Chol-induced or-
dering of the phospholipid bilayer, than is the binding of GS10 and GS.
For example, the binding of GS14dK4 to zwitterionic POPC LUVs is some-
what weaker than that of GS10 but much weaker than that of GS, and
GS14dK4 does not exhibit detectable binding to POPC/Chol (3:2) LUVs,
whereas GS10 and GS binding to POPC LUVs is only weakened moder-
ately or little, respectively, by the presence of Chol. In contrast,
GS14dK4 binds only slightly less tightly to anionic POPG LUVs than
does GS, although the binding of GS14dK4 to POPG/Chol (3:2) LUVs is
markedly reduced, while the binding of GS10 and GS to POPG LUVs is
moderately and little affected by the presence of Chol, respectively.
Moreover, the binding of GS14dK4 to all phospholipid vesicles studied
is accompanied bymuchhigher positiveΔH values, but alsomuch larger
ΔS and TΔS values, than is GS10 and especially GS binding, such that the
afﬁnity and ΔG values for binding for GS14dK4 vary over a much larger
range in different lipid vesicles than is the case for either GS10 or GS.
In principle, many of the ITC data discussed above can be rational-
ized by a consideration of the relative sizes and charge densities of the
GS14dK4, GS10 and GS molecules. Since GS14dK4 is considerably larger
than is GS10 or GS, it should be more energetically costly to insert this
peptide molecule into phospholipid vesicles, particularly those not
bearing a negative surface charge and those exhibiting Chol-induced
decreases in ﬂuidity and increases in order, as is indeed observed. This
suggestion is supported by the relatively much higher positive ΔH
values associated with GS14dK4 binding to phospholipid vesicles,
particularly those containing Chol. In contrast, the larger size of the
GS14dK4 molecule, and the fact that the somewhat polar and charged
D-Lys residue projects toward to hydrocarbon chains of the phospholip-
id molecules rather than toward the polar headgroups, would tend to
more strongly disorder the host phospholipid bilayer, again consistent
with the higher ΔS and TΔS values observed on the binding of
GS14dK4 as compared to GS, particularly in Chol-containing phospho-
lipid vesicles. On the other hand, the GS14dK4 molecule contains three
positively charged Lys residues positioned to interactwith thephospho-
lipid polar headgroups, while GS10 and GS contain only two positively
charged Lys or Orn residues so positioned. Thus GS14dK4 binding to
1428 T. Abraham et al. / Biochimica et Biophysica Acta 1838 (2014) 1420–1429anionic phospholipid vesicles through increased electrostatic interac-
tions might not be reduced as greatly compared to GS itself, despite its
larger size, as in the case of zwitterionic phospholipid vesicles. These
results would largely explain the retained antimicrobial activity but
greatly reduced hemolytic activity of GS16dK4 as compared to GS and
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